These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30168712)

  • 1. Simultaneous Assay of Oxygen-Dependent Cytotoxicity and Genotoxicity of Anticancer Drugs on an Integrated Microchip.
    Li L; Li Y; Shao Z; Luo G; Ding M; Liang Q
    Anal Chem; 2018 Oct; 90(20):11899-11907. PubMed ID: 30168712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting.
    Delahoussaye YM; Hay MP; Pruijn FB; Denny WA; Brown JM
    Biochem Pharmacol; 2003 Jun; 65(11):1807-15. PubMed ID: 12781332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of oxygen and chemical concentration gradients in a single microfluidic device for studying tumor cell-drug interactions in a dynamic hypoxia microenvironment.
    Wang L; Liu W; Wang Y; Wang JC; Tu Q; Liu R; Wang J
    Lab Chip; 2013 Feb; 13(4):695-705. PubMed ID: 23254684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microfluidic cell culture array with various oxygen tensions.
    Peng CC; Liao WH; Chen YH; Wu CY; Tung YC
    Lab Chip; 2013 Aug; 13(16):3239-45. PubMed ID: 23784347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell-Arrayed Agarose Chip for in Situ Analysis of Cytotoxicity and Genotoxicity of DNA Cross-Linking Agents.
    Li L; Wang W; Ding M; Luo G; Liang Q
    Anal Chem; 2016 Jul; 88(13):6734-42. PubMed ID: 27269449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
    Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
    Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
    Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polydimethylsiloxane-polycarbonate hybrid microfluidic device capable of generating perpendicular chemical and oxygen gradients for cell culture studies.
    Chang CW; Cheng YJ; Tu M; Chen YH; Peng CC; Liao WH; Tung YC
    Lab Chip; 2014 Oct; 14(19):3762-72. PubMed ID: 25096368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tirapazamine is metabolized to its DNA-damaging radical by intranuclear enzymes.
    Evans JW; Yudoh K; Delahoussaye YM; Brown JM
    Cancer Res; 1998 May; 58(10):2098-101. PubMed ID: 9605751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA replication by tirapazamine.
    Peters KB; Wang H; Brown JM; Iliakis G
    Cancer Res; 2001 Jul; 61(14):5425-31. PubMed ID: 11454687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis.
    Yuan JM; Wei K; Zhang GH; Chen NY; Wei XW; Pan CX; Mo DL; Su GF
    Eur J Med Chem; 2019 May; 169():144-158. PubMed ID: 30875505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of oxygen gradients in microfluidic devices for cell culture using spatially confined chemical reactions.
    Chen YA; King AD; Shih HC; Peng CC; Wu CY; Liao WH; Tung YC
    Lab Chip; 2011 Nov; 11(21):3626-33. PubMed ID: 21915399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Microfluidic Platform with Multiple Functions To Probe Tumor-Endothelial Cell Interaction.
    Lin L; Lin X; Lin L; Feng Q; Kitamori T; Lin JM; Sun J
    Anal Chem; 2017 Sep; 89(18):10037-10044. PubMed ID: 28820578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):529-36. PubMed ID: 7880735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tirapazamine: a hypoxia-activated topoisomerase II poison.
    Peters KB; Brown JM
    Cancer Res; 2002 Sep; 62(18):5248-53. PubMed ID: 12234992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent.
    Yang B; Reynolds CP
    Clin Cancer Res; 2005 Apr; 11(7):2774-80. PubMed ID: 15814660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impedimetric toxicity assay in microfluidics using free and liposome-encapsulated anticancer drugs.
    Caviglia C; Zór K; Montini L; Tilli V; Canepa S; Melander F; Muhammad HB; Carminati M; Ferrari G; Raiteri R; Heiskanen A; Andresen TL; Emnéus J
    Anal Chem; 2015 Feb; 87(4):2204-12. PubMed ID: 25582124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.